Articles written specifically for the GLP or articles that are reposted from other sources (sometimes in modified form) by agreement or with permission list the source as Genetic Literacy Project. Excerpted articles posted in our Daily Digests are identified as excerpts of posts culled from the web. Each Daily Digest post lists the original media outlet as the source next to the name of the author. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair use policy for posting excerpts and using images is explained here.
FDA v LDT

FDA action against 23andMe doesn’t signal the end for personal genomics

Jennifer K. Wagner | Genomics Law Report | 
Many have speculated that the FDA action against 23andMe spells an end for personal genomics. But according to a new ...
baby

Is the ‘designer baby’ debate more about gene patentability?

Jonathan Webber | Genomics Law Report | 
The controversial "designer baby" debate speaks to the larger issues about patent eligibility and the patent application process, according to ...
Sequencing Money x

Genetic testing service deCODEme shutting down in wake of Amgen/deCODE deal

Dan Vorhaus | Genomics Law Report | 
After the $415 million sale of deCODE Genetics to Amgen, deCODE's deCODEme direct-to-consumer genomic screening service will be shut down ...

Amgen buys deCODE: What are the implications for genetic testing customers?

Dan Vorhaus | Genomics Law Report | 
The big biotech news of the day is the $415 million sale of deCODE Genetics to Amgen. Coverage of the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists